Keros Therapeutics (KROS) Net Margin (2019 - 2026)
Keros Therapeutics' Net Margin came in at -6093.77% for Q4 2025, down 4580.75 percentage points from -1513.02% a year earlier and down 6042.72 percentage points from the prior quarter.
Powered by 
Analysis
Keros Therapeutics (KROS) Net Margin (2019 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics' Net Margin was 35.65%, up 5313.20 percentage points from FY2024.
- Net Margin carries a four-year change of +327.91 percentage points (FY2021 to FY2025).
- Going back by year, Net Margin was -5277.55% in FY2024 (+96041.66 pp), -101319.21% in FY2023 and -292.26% in FY2021.
- The Q4 2025 figure represents the lowest quarterly Net Margin since Q3 2024.
- Year-over-year, Net Margin increased in five of the last six quarters, with an average year-over-year change of +114859.88 percentage points.
- Business Quant data shows KROS's Net Margin at -51.04% (Q3 2025), -168.96% (Q2 2025) and 70.27% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 35.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.37% |
| Mar 31, 2026 | -6,459.95% |
| Dec 31, 2025 | -6,093.77% |
| Sep 30, 2025 | -51.04% |
| Jun 30, 2025 | -168.96% |
| Mar 31, 2025 | 70.27% |
| Dec 31, 2024 | -1,513.02% |
| Sep 30, 2024 | -13,648.45% |
| Jun 30, 2024 | -122,316.22% |
| Mar 31, 2024 | -51,944.58% |
| Dec 31, 2023 | -28,141.96% |
| Sep 30, 2023 | -493,000.00% |
| Mar 31, 2022 | -134.37% |
| Dec 31, 2021 | -34.70% |
| Jun 30, 2021 | -15,622.00% |
| Dec 31, 2019 | -128.04% |
| Sep 30, 2019 | -159.96% |
| Jun 30, 2019 | -132.12% |
| Mar 31, 2019 | -145.32% |
API Access
Keros Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();